Algorithms for assessing the probability of an Adverse Drug Reaction

Respiratory Medicine CME

Volumn 2, Issue 2, 2009, Pages 63-67

  Doherty, Martin J ^a  

^a DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Adverse Drug Reactions; Algorithms; Causality; Rechallenge

Indexed keywords

ACETYLSALICYLIC ACID; BISOPROLOL; DIURETIC AGENT; ENALAPRIL; FLUTICASONE PROPIONATE PLUS SALMETEROL; MONTELUKAST; OLANZAPINE; OMALIZUMAB; OMEPRAZOLE; PERINDOPRIL; PREDNISOLONE; SALBUTAMOL; SIMVASTATIN; THEOPHYLLINE; TIOTROPIUM BROMIDE;

ACHILLES TENDINITIS; ALGORITHM; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL DECISION MAKING; DRUG WITHDRAWAL; HEEL PAIN; HOSPITAL ADMISSION; HUMAN; MORBIDITY; MORTALITY; NEPHROTIC SYNDROME; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PROTEINURIA; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SCHIZOPHRENIA; THORAX PAIN;

EID: 64649091563     PISSN: 17550017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmedc.2009.01.004     Document Type: Article

References (19)

1. Requirements for adverse drug monitoring (1975), World Health Organisation, Geneva, Switzerland
2. Pirmohamed M., et al. Adverse drug reactions as a cause of admission to hospital: prospective analysis of 18820 patients. BMJ 329 (2004) 15-19
3. Proceedings of the British Pharmacological Society 75th Anniversary Meeting clinical pharmacology section (December 2006). Br J Pharmacol 63 6 (2007) 776
4. Lazarou J., Pomeranz B.H., and Corey P.N. Incidence of adverse reactions in hospitalized patients; a Meta analysis of prospective studies. J Am Med Assoc 279 (1998) 1200-1205
5. Manasse H.R. Medication use in an imperfect world: drug misadventuring as an issue of public policy, part 1. Am J Hosp Pharm 46 (1989) 929-944
6. Laepe L.L., Brennan T.A., and Laird N. The nature of adverse events in hospitalized patients. Results of the Harvard medical practice study II. New Engl. J Med 324 (1991) 377-384
7. Blanc S., Leuenberger P., Berger J.P., Brooke M., and Schelling J.L. Judgements of trained observers on adverse drug reactions. Clin Pharmacol Ther 25 (1979) 493-498
8. Karsh F.E., Smith C.L., Kerzner B., Mazzullo J.M., Weintraub M., and Lasanga L. Adverse drug reactions. A matter of opinion. Clin Pharmacol Ther 19 (1976) 489-492
9. Naranjo C.A., Busto U., Sellars E.M., Sandor P., Ruiz I., Roberts E.A., and Janecek E. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30 (1981) 239-245
10. Naranjo C.A., Busto U., Abel J.G., et al. Empiric delineation of the probability spectrum of adverse drug reactions. Clin Pharmacol Ther 29 (1981) 267-268
11. Jones J.K. Adverse drug reactions in the community health setting; approaches to recognizing, counseling and reporting. Fam Community Health 5 2 (1982) 58-67
12. Kramer M.S., and Hutchinson T.A. The Yale algorithm. Special workshop-clinical. Drug Inf J 18 (1984) 283-291
13. Karch F.E., and Lasagna L. Towards the operational identification of adverse drug reaction. Clin Pharmacol Ther 21 (1977) 247-254
14. Begaud B., Evreux J.C., Jouglard J., and Lagier G. Imputation of the unexpected or toxic effects of drugs. Actualisation of the methods used in France. Therapie 40 (1985) 115-118
15. Mashford M.I. The Australian method of drug event assessment. Drug Inf J 18 (1984) 271-273
16. WHO-UMC causality assessment system. Available from: .
17. Koh Y., Chu W.Y., and Shu C.L. A quantitative approach using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system. Int J Med Inf 77 (2008) 421-430
18. Michel D.J., and Knodel L.C. Comparison of three algorithms used to evaluate adverse drug reactions. Am J Hosp Pharm 43 (1986) 1709-1714
19. Meyboom R.H., Hekster Y.A., Egberts A.C., Gribnau F.W., and Edwards I.R. Causal or casual? The role of causality assessment in pharmacovigilence. Drug Saf 17 6 (1997) 374-389